VivoSeq
Other

Acute Cough

0

Pipeline Programs

1

Active Trials

2

Companies Involved

Acute Cough is an early-stage landscape with 0 programs across 2 companies. The most active players are Pfizer, Tasly Pharmaceutical Group Co., Ltd.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

25/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

8

clinical trials

Completed3 · 38%
Unknown status2 · 25%
Terminated2 · 25%
Not yet recruiting1 · 13%

Trial Activity

8 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)